Primary sclerosing cholangitis is a chronic liver disease characterized by inflammation and progressive scarring of the bile ducts, impeding bile flow and ultimately leading to liver damage.
Hyperbaric oxygen therapy may potentially alleviate complications of primary sclerosing cholangitis by enhancing tissue oxygenation and reducing inflammation in bile ducts.